Apolipoprotein A-I-derived amyloid in atherosclerotic plaques of the human aorta

被引:0
|
作者
Mucchiano, GI [1 ]
Häggqvist, B
Sletten, K
Westermark, P
机构
[1] Hogland Hosp, Div Mol & Immunol Pathol, Adm Unit, S-57581 Eksjo, Sweden
[2] Linkoping Univ, Div Mol & Immunol Pathol, S-58183 Linkoping, Sweden
[3] Univ Oslo, Dept Biochem, Oslo 3, Norway
[4] Univ Oslo, Biotechnol Ctr Oslo, Oslo 3, Norway
[5] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden
来源
JOURNAL OF PATHOLOGY | 2001年 / 193卷 / 02期
关键词
amyloid; aorta; intima; apolipoprotein A-1; atherosclerosis; immunocytochemistry;
D O I
10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have shown that the amyloid localized to the aortic intima may be a biochemical entity different from other forms of localized amyloid, The amyloid fibril protein in one patient studied consisted of an N-terminal fragment of apolipoprotein A-1 (apo A-1). Since this patient was later shown to carry a missense mutation in the apo A-1 gene, leading to a deletion at position 107 of the mature protein, the question remained whether wild-type apo A-1 is amyloidogenic. In autopsy specimens from the thoracic aorta from 69 individuals, intimal atherosclerotic plaque-related amyloid was present in 11 cases (16%) and amyloid outside plaques in 37 cases (54%), The immunoreactivity of amyloid localized to the aortic intima was evaluated with the aid of antisera against N-terminal segments of apo A-1, The amyloid in association with atherosclerotic plaques was positively labelled by immunohistochemistry. The amyloid fibril protein from one patient, previously shown not to carry any mutation in the apo A-1 gene, was purified and shown by amino acid sequence analysis to be of apo A-1 nature. The result shows that wild-type apo A-1 is amyloidogenic and gives rise to a common localized form of amyloid associated with atherosclerosis, Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 50 条
  • [41] MONOCLONAL IMMUNOLOCALIZATION OF APOLIPOPROTEIN-B, APOLIPOPROTEIN-A-I, AND APOLIPOPROTEIN-E IN HUMAN ATHEROSCLEROTIC PLAQUE
    DETORRES, WR
    ISNER, JM
    SCHAEFER, EJ
    DONALDSON, RF
    LECHAN, RM
    CLINICAL RESEARCH, 1986, 34 (02): : A293 - A293
  • [42] Cellular localization of apolipoprotein A-I in human atherosclerotic lesions.
    Lin, GR
    Oram, JA
    O'Brien, KD
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 53A - 53A
  • [43] TOCOPHEROL IN THE ATHEROSCLEROTIC HUMAN AORTA
    MCCORMICK, EC
    MCCLUER, RH
    CIRCULATION, 1960, 22 (04) : 786 - 786
  • [44] Bacterial profile in human atherosclerotic plaques
    Jonsson, Annika Lindskog
    Hallenius, Frida Fak
    Akrami, Rozita
    Johansson, Elias
    Wester, Per
    Arnerlov, Conny
    Backhed, Fredrik
    Bergstrom, Goran
    ATHEROSCLEROSIS, 2017, 263 : 177 - 183
  • [45] ANGIOGENESIS IN HUMAN CORONARY ATHEROSCLEROTIC PLAQUES
    OBRIEN, ER
    GARVIN, MR
    DEV, R
    STEWART, DK
    HINOHARA, T
    SIMPSON, JB
    SCHWARTZ, SM
    AMERICAN JOURNAL OF PATHOLOGY, 1994, 145 (04): : 883 - 894
  • [46] Dating components of human atherosclerotic plaques
    Goncalves, I.
    Stenstrom, K.
    Skog, G.
    Mattsson, S.
    Nitulescu, M.
    Nilsson, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 794 - 794
  • [47] MONOCLONAL ORIGIN OF HUMAN ATHEROSCLEROTIC PLAQUES
    PEARSON, TA
    WANG, AL
    SOLEZ, K
    HEPTINSTALL, RH
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 876 - 876
  • [48] INSOLUBLE LIPIDS IN HUMAN ATHEROSCLEROTIC PLAQUES
    MITCHINSON, MJ
    ATHEROSCLEROSIS, 1982, 45 (01) : 11 - 15
  • [49] Microsatellite instability in human atherosclerotic plaques
    Spandidos, DA
    Ergazaki, M
    Arvanitis, D
    Kiaris, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) : 137 - 140
  • [50] LABILITY OF CHOLESTEROL IN HUMAN ATHEROSCLEROTIC PLAQUES
    GOULD, RG
    JONES, RJ
    WISSLER, RW
    CIRCULATION, 1959, 20 (05) : 967 - 967